Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 17, 2023 Filed May 17, 2023 20:11 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 7,099 $18.12 $128,633.88
Disclosure

SEC source: 0001628280-23-018684 · wf-form4_168435429831173.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,345

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F3 · price: This is a weighted average sales price representing 7,099 shares sold at prices ranging from $18.12 to $18.13 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 17, 2023 Filed May 17, 2023 20:07 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 2,448 $18.12 $44,357.76
Disclosure

SEC source: 0001628280-23-018673 · wf-form4_168435404211099.xml · nonDerivative · entry 3

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,333

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:16 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 381 $18.44 $7,025.64
Disclosure

SEC source: 0001628280-23-018700 · wf-form4_168435453768194.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,960

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:13 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 1,217 $18.45 $22,453.65
Disclosure

SEC source: 0001628280-23-018691 · wf-form4_168435436955097.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,497

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:14 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
SaleCommon Stock 475 $18.43 $8,754.25
Disclosure

SEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,345

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 475 shares sold at prices ranging from $18.40 to $18.45 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:11 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 3,714 $18.41 $68,374.74
Disclosure

SEC source: 0001628280-23-018684 · wf-form4_168435429831173.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,444

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:09 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 1,610 $18.47 $29,736.70
Disclosure

SEC source: 0001628280-23-018679 · wf-form4_168435416317222.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,619

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:10 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 1,718 $18.43 $31,662.74
Disclosure

SEC source: 0001628280-23-018681 · wf-form4_168435423354522.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,906

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F3 · price: This is the weighted average sales price representing 1,718 shares sold at prices ranging from $18.43 to $18.47 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 16, 2023 Filed May 17, 2023 20:07 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 1,521 $18.39 $27,971.19
Disclosure

SEC source: 0001628280-23-018673 · wf-form4_168435404211099.xml · nonDerivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,781

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:16 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 593 $19.29 $11,438.97
Disclosure

SEC source: 0001628280-23-018700 · wf-form4_168435453768194.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,341

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 593 shares sold at prices ranging from $19.29 to $19.30 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:13 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 1,830 $19.22 $35,172.60
Disclosure

SEC source: 0001628280-23-018691 · wf-form4_168435436955097.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,714

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:14 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
SaleCommon Stock 1,897 $19.24 $36,498.28
Disclosure

SEC source: 0001628280-23-018696 · wf-form4_168435443742523.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,820

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 1,897 shares sold at prices ranging from $19.24 to $19.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:11 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 6,048 $19.23 $116,303.04
Disclosure

SEC source: 0001628280-23-018684 · wf-form4_168435429831173.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,158

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is a weighted average sales price representing 6,048 shares sold at prices ranging from $19.21 to $19.24 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:09 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 2,210 $19.30 $42,653.00
Disclosure

SEC source: 0001628280-23-018679 · wf-form4_168435416317222.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,229

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,210 shares sold at prices ranging from $19.29 to $19.32 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:10 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 2,576 $19.28 $49,665.28
Disclosure

SEC source: 0001628280-23-018681 · wf-form4_168435423354522.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,624

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,576 shares sold at prices ranging from $19.27 to $19.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:07 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 2,847 $19.27 $54,861.69
Disclosure

SEC source: 0001628280-23-018673 · wf-form4_168435404211099.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,302

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,847 shares sold at prices ranging from $19.26 to $19.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:06 UTC PurchaseCommon Stock 10,000 $19.29 $192,900.00
Disclosure

SEC source: 0001628280-23-018666 · wf-form4_168435394565987.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Padonia, LLC

Disclosed balance after: 10,000

F2 · price: This is the weighted average purchase price representing 10,000 shares purchased at prices ranging from $19.22 to $19.34 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

F3 · ownership.nature: The Reporting Person is the managing member of Padonia, LLC.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:06 UTC PurchaseCommon Stock 10,000 $19.29 $192,900.00
Disclosure

SEC source: 0001628280-23-018666 · wf-form4_168435394565987.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,615

F1 · price: This is the weighted average purchase price representing 10,000 shares purchased at prices ranging from $19.22 to $19.35 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option · Derivative 83,333 $12.44 Strike: $12.44 $1,036,662.52
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 8

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By ARTICLE 4 KATIE PROCTER DYNASTY TRUST

Disclosed balance after: 0

Underlying: Common Stock · 83,333 shares

Expires 2023-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 83,334 $12.44 Strike: $12.44 $1,036,674.96
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST

Disclosed balance after: 0

Underlying: Common Stock · 83,334 shares

Expires 2023-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 67,257 $12.44 Strike: $12.44 $836,677.08
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 6

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST

Disclosed balance after: 0

Underlying: Common Stock · 67,257 shares

Expires 2023-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 83,334 $12.44 $1,036,674.96
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Indirect

Disclosed balance after: 233,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · ownership.nature: By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 83,333 $12.44 $1,036,662.52
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Indirect

Disclosed balance after: 150,590

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · ownership.nature: By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust.

Read SEC document
May 12, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 67,257 $12.44 $836,677.08
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Indirect

Disclosed balance after: 67,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · ownership.nature: By ARTICLE 4 TRUST UNDER KATIE PROCTER DYNASTY TRUST, of which the reporting person is a trustee. The reporting person and members of the reporting person's immediate family are the sole beneficiaries of the trust.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:25 UTC GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018209 · wf-form4_168418233227543.xml · nonDerivative · entry 1

SCHAFER CAROL · CIK 0001272181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,097

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:27 UTC GiftCommon Stock 1,800 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-018211 · wf-form4_168418241982699.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,615

Read SEC document
May 11, 2023 Filed May 15, 2023 20:27 UTC GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018211 · wf-form4_168418241982699.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,415

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:24 UTC GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018207 · wf-form4_168418226315938.xml · nonDerivative · entry 1

MCGIRR DAVID W J · CIK 0001219023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,753

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:23 UTC
LEE LEODirector
GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018205 · wf-form4_168418220866282.xml · nonDerivative · entry 1

LEE LEO · CIK 0001740789 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,457

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:22 UTC GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018201 · wf-form4_168418215072198.xml · nonDerivative · entry 1

Desjardins Clarissa · CIK 0001793390 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,787

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:21 UTC GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018200 · wf-form4_168418208788013.xml · nonDerivative · entry 1

Brennan David R · CIK 0001609305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,713

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:20 UTC GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018198 · wf-form4_168418201428060.xml · nonDerivative · entry 1

ANDERSON ELIZABETH M · CIK 0001758247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,509

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:19 UTC GrantCommon Stock 13,192 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018193 · wf-form4_168418195780663.xml · nonDerivative · entry 1

ALTOMARI ALFRED · CIK 0001285644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,333

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:15 UTC
Wise John DraytonChief Commercial Officer
GrantStock Option (right to buy) · Derivative 146,220 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018183 · wf-form4_168418171156141.xml · derivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,220

Underlying: Common Stock · 146,220 shares

Expires 2033-05-11

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:15 UTC
Wise John DraytonChief Commercial Officer
GrantCommon Stock 31,662 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018183 · wf-form4_168418171156141.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,934

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:14 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
GrantStock Option (right to buy) · Derivative 121,850 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · derivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,850

Underlying: Common Stock · 121,850 shares

Expires 2033-05-11

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:14 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
GrantCommon Stock 26,385 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018180 · wf-form4_168418166701360.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,717

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:13 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantStock Option (right to buy) · Derivative 121,850 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018174 · wf-form4_168418156777258.xml · derivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,850

Underlying: Common Stock · 121,850 shares

Expires 2033-05-11

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:13 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantCommon Stock 26,385 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018174 · wf-form4_168418156777258.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,544

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
GrantStock Option (right to buy) · Derivative 430,140 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · derivative · entry 5

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430,140

Underlying: Common Stock · 430,140 shares

Expires 2033-05-11

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:12 UTC
Lewis WilliamDirector · Chair and CEO
GrantCommon Stock 93,139 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018171 · wf-form4_168418150462788.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 358,206

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:10 UTC
Flammer Martina M.D.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 146,220 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018167 · wf-form4_168418140031650.xml · derivative · entry 3

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,220

Underlying: Common Stock · 146,220 shares

Expires 2033-05-11

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:10 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 14,775 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018167 · wf-form4_168418140031650.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,200

F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:10 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 31,662 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018167 · wf-form4_168418140031650.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,425

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:08 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock · Derivative 158,410 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018160 · wf-form4_168418128865059.xml · derivative · entry 3

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,410

Underlying: Common Stock · 158,410 shares

Expires 2033-05-11

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:08 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock 21,108 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018160 · wf-form4_168418128865059.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,439

F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:08 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock 34,300 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018160 · wf-form4_168418128865059.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,331

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:06 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock · Derivative 146,220 $0.00 Strike: $18.95 $0.00
Disclosure

SEC source: 0001628280-23-018152 · wf-form4_168418117556876.xml · derivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,220

Underlying: Common Stock · 146,220 shares

Expires 2033-05-11

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
May 11, 2023 Filed May 15, 2023 20:06 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock 31,662 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-018152 · wf-form4_168418117556876.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,149

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 20:11 UTC GiftCommon Stock 3,798 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-012309 · form4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,223

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.